{
    "clinical_study": {
        "@rank": "132646", 
        "arm_group": [
            {
                "arm_group_label": "Telemedicine", 
                "arm_group_type": "Experimental", 
                "description": "Monthly video consultations with a nurse as add-on to standard treatment."
            }, 
            {
                "arm_group_label": "Standard treatment", 
                "arm_group_type": "No Intervention", 
                "description": "Standard diabetes control at a Diabetes Clinic or GP"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to investigate the effect of telemedicine among the group of\n      type-2-diabetics who, despite rehabilitation, remain poorly regulated.  To describe the\n      patients with regards to vulnerability and social resources and to determine wich groups\n      benefit the most from telemedicine."
        }, 
        "brief_title": "Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Type 2 Diabetes", 
            "Poor Glycemic Control", 
            "Medication Adherence"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "Type-2-diabetes is a growing healthcare problem. Both because of the increasing amount of\n      patients and because of the complications of diabetes.\n\n      Non-pharmacological treatment is considered fundamental in the treatment of patients with\n      type-2-diabetes.\n\n      In the Community of Copenhagen, all patients diagnosed with diabetes receive\n      rehabilitation. The rehabilitation consists of counseling with regards to nutrition,\n      physical activity, smoking cessation and education about diabetes.\n\n      Some patients however, remain poorly regulated despite rehabilitation as well as\n      pharmacological treatment.\n\n      A total number of 165 patients will be randomized to intervention group or standard care."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  HbA1c > 7,5%\n\n          -  BMI > 25\n\n          -  Spoken danish\n\n          -  Completed a rehabilitation program more than 6 months ago\n\n        Exclusion Criteria:\n\n          -  HbA1c < 7,5%\n\n          -  BMI < 25\n\n          -  Need of interpreter"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "165", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688778", 
            "org_study_id": "H-2-2011-158"
        }, 
        "intervention": {
            "arm_group_label": "Telemedicine", 
            "description": "Monthly video consultations with a nurse as add-on to standard treatment. The nurse has access to bloodsugar- bloodpressure and weight measurements uploaded by the participants to a tablet computer directly from the devices.\nPatients on Insulin measure bloodsugar twice a day (fasting and before their evening meal). Patients not on Insulin measure bloodsugar once a week (fasting and before their evening meal). All participants measure bloodpressure and weight once a week. The intervention lasts 32 weeks.", 
            "intervention_name": "Telemedicine", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 2 diabetes", 
            "Quality of life", 
            "Lifestyle intervention", 
            "Telemedicine", 
            "Videoconference"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "Copenhagen NV", 
                    "zip": "DK-2400"
                }, 
                "name": "Endocrine Section, Dept. of Internal Medicine I, Bispebjerg Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes", 
        "other_outcome": [
            {
                "measure": "Number of hospital admissions", 
                "safety_issue": "No", 
                "time_frame": "32 weeks"
            }, 
            {
                "measure": "Number of visits at the emergency", 
                "safety_issue": "No", 
                "time_frame": "32 weeks"
            }, 
            {
                "measure": "Number of visits at the outpatient department", 
                "safety_issue": "No", 
                "time_frame": "32 weeks"
            }, 
            {
                "measure": "Number of visits at GP", 
                "safety_issue": "No", 
                "time_frame": "32-weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Endocrine Section, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark", 
            "last_name": "Caroline Raun Hansen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: The Regional Committee on Biomedical Research Ethics"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes in HbA1c", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 16 weeks, 32 weeks, 6 months after intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688778"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bispebjerg Hospital", 
            "investigator_full_name": "Caroline Raun Hansen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Fasting total cholesterol, LDL, HDL, triglycerides", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Beta-cell function test (HOMA)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Bloodpressure", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Physical activity", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Change in quality of life", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Waist circumference", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Hip circumference", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Body mass index", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }, 
            {
                "measure": "Use of medication", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 32 weeks"
            }
        ], 
        "source": "Bispebjerg Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "The Health and Care Committee, Copenhagen City Council", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Bispebjerg Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}